Mark de Caestecker
Professor of Medicine · Vanderbilt University Medical Center
Credentials: · · ·
History
Present- Present
- 1986–1988
Nephrology
- 1983–1986
Internal Medicine
- 1979–1983
Research
Role of transforming growth factor-beta signaling in cancer
Journal of the National Cancer Institute · 2000 · First of 3 authors · 449 citations
The transforming growth factor-beta superfamily of receptors
Review · Cytokine & Growth Factor Reviews · 2004 · Sole author · 359 citations
The FASEB Journal · 2003 · 325 citations
17 papers
11 papers
- RL
10 papers
8 papers · 2 as a fellow
6 papers · 6 as a resident
5 papers
4 papers
- YZ
4 papers · 2 as a resident
Grants
- 2022–2027
Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $3.5M · Georgia State University
- 2020–2025
Therapeutic Optimization of Productive Repair After Acute Kidney Injury
National Institute of Diabetes and Digestive and Kidney Diseases · UC2
PI · $3.2M · University of Pittsburgh at Pittsburgh
- 2017–2023
Vanderbilt O'Brien Kidney Center
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $316K · Vanderbilt University Medical Center
- 2022–2023
FASEB SRC: The 2nd Acute Kidney Injury Conference: From Bench to Bedside
National Institute of Diabetes and Digestive and Kidney Diseases · R13
Contact PI · $10K · Federation of Amer Soc for Exper Biology